2011 Q1/Global Life Sciences


Summary

Full results


Changes in rank are compared to 2010 Q4/Global Life Sciences. Since then, 31 sites entered the survey and 12 sites could not be included in the rankings (4 more since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
new Cilag AG 8.31
+ 31 Actelion Ltd. 8.18
same Lumavita AG 8.12
- 2 Newron 8.03
- 1 Medinova AG 7.85
same Nycomed Pharma AG 7.82
- 2 Axentis Pharma AG 7.72
- 7 Neurimmune Therapeutics AG 7.30
+ 33 Antares Pharma AG 7.11
- 3 ArisGen SA 7.03
new Takeda Pharma AG 6.85
new Pharmakon Ltd. 6.79
+ 1 Arpida AG 6.76
+ 25 Med Discovery S.A. 6.75
+ 9 Neurotune 6.69
new Pentapharm (DSM Nutritional Products AG) 6.68
- 8 BioPartners GmbH 6.68
- 8 4-Antibody AG 6.67
new Dr. Wild & Co. AG 6.62
- 9 OMIDA AG 6.58
- 4 AmVac AG 6.51
same Evolva SA 6.40
+ 13 Johnson & Johnson Pharmaceutical Research & Development 6.32
- 8 Tricom GmbH, Pharma Division 6.32
new GlaxoSmithKline AG 6.31
- 18 Siegfried AG 6.30
+ 1 Auris Medical AG 6.23
- 10 Max Zeller Söhne AG 6.22
- 8 Molecular Partners 6.15
- 5 Kuros Biosurgery AG 6.13
new Virbac Schweiz AG 6.06
- 9 Cytos Biotechnology AG 6.05
new Teva Pharma AG 6.05
- 15 GKL Biotec AG 5.94
- 9 Octapharma AG 5.91
- 9 Lipideon Biotechnology AG 5.88
- 24 Biogen Idec International GmbH 5.86
- 8 Vifor (International) Ltd. 5.74
- 7 Helvepharm AG 5.74
+ 5 Novartis International AG 5.72
- 10 Galenica Ltd. 5.71
+ 13 Permamed AG 5.66
+ 31 AstraZeneca AG 5.60
new A. Menarini AG 5.59
new Sanofi-Aventis 5.57
new Merz Pharma (Schweiz) AG 5.56
- 6 Anavex Life Sciences Corp. 5.54
- 36 Axenoll AG 5.51
new Bristol-Myers Squibb SA 5.47
- 21 BioVersys GmbH 5.45
- 16 Addex Pharmaceuticals 5.41
- 2 Ferring International Center SA 5.40
+ 7 Novo Nordisk Pharma AG 5.38
new AstraZeneca 5.32
- 18 Novelty Pharma Galenical Development and Documentation 5.31
new Acino Holding AG 5.24
- 37 F. Hoffmann-La Roche AG (CH) 5.17
+ 1 Spirig Pharma AG 5.12
+ 14 Debiopharm S.A. 5.02
- 14 Basilea Pharmaceutica Ltd. 4.97
new Abbott Laboratories 4.95
- 6 Solvay Pharma AG 4.94
- 23 Lunamed AG 4.83
- 17 Aurora Pharma GmbH 4.71
- 31 Nycomed International Management GmbH 4.66
- 18 Ergonex Pharma GmbH 4.58
- 24 Mundipharma Medical Company 4.58
- 30 Covagen AG 4.53
- 25 AC Immune SA 4.48
- 21 Kenta Biotech AG 4.48
- 18 CSL Behring AG 4.40
new Boehringer Ingelheim Schweiz GmbH 4.35
- 58 F. Hoffmann-La Roche AG (Worldwide) 4.32
- 22 Medipol SA 4.31
new LEO Pharmaceutical Products Sarath Ltd. 4.23
new Tillotts Pharma AG 4.22
- 20 3-V Biosciences GmbH 4.21
new MEDA Pharma GmbH 4.17
- 21 GlycoVaxyn AG 4.12
- 12 Streuli Pharma AG 4.12
- 20 NovImmune 4.08
+ 2 mondoBIOTECH AG 3.95
- 29 Mepha Pharma AG 3.87
- 22 Nitec Pharma AG 3.78
- 22 Novartis Pharma Schweiz AG 3.76
new Multipharma 3.68
new Eli Lilly 3.67
- 5 Merck Serono International SA 3.63
- 24 Medena 3.61
- 20 Gruenenthal Pharma AG 3.60
- 24 Crucell | Berna Biotech Ltd 3.58
new Johnson & Johnson 3.52
- 21 OM PHARMA 3.34
new Lundbeck (Schweiz) AG 3.33
new Galderma Pharma SA 3.30
new Pfizer 3.20
- 28 Redbiotec AG 3.17
new PFC Pharma Focus Switzerland 3.16
- 24 Cryo-Save AG 3.12
- 24 ESBATECH AG 3.04
- 30 Bayer Schweiz AG 2.99
- 25 GeNeuro SA 2.96
- 37 PharmaSwiss SA - HQ 2.71
new GlaxoSmithKline 2.70
- 20 GenKyoTex SA 2.61
- 26 Schwabe Pharma AG 2.53
- 26 Merck Sharp & Dohme-Chibret AG 2.47
- 29 Baxter Switzerland 2.36
new Bristol-Myers Squibb 2.24
new Geistlich Pharma AG 2.16
- 29 APR Applied Pharma Research s.a. 2.15
new Genzyme GmbH 2.01
new Merck 1.88
- 28 Helsinn Healthcare S.A. 1.83
- 37 Neurim Pharmaceuticals S.A. 1.75